MYGN — MYRIAD GENETICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 205 家机构在其最新 13F 申报中持有 MYGN(MYRIAD GENETICS INC),合计申报市值 $564.27M,对应 98.95M 股。按股数计算较上季度增持 9.1%(+7.67M 股),申报市值环比上升 38.4%。持仓集中度较高:前五大持有人占申报市值的 34.9%,前十大的集中度为 52.3%。
与上一季度相比,49 家新建仓位、72 家加仓、60 家减仓、52 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
MYRIAD GENETICS INC(MYGN)的主要机构持有人包括 ORBIMED ADVISORS LLC、BlackRock Inc、LOOMIS SAYLES & CO L P,按 13F 申报市值在本页 458 家持有人中排名居前。
MYGN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 123 | 50.85M | $219.32M | +8.5% |
| Q2 2026 | 205 | 98.95M | $564.27M | +9.1% |
| Q1 2026 | 208 | 225.30M | $573.88M | -2.9% |
| Q4 2025 | 226 | 106.83M | $657.27M | +8.0% |
| Q3 2025 | 221 | 99.49M | $718.75M | +2.4% |
| Q2 2025 | 214 | 95.96M | $509.31M | +14.4% |
| Q1 2025 | 225 | 100.10M | $887.30M | +1.7% |
| Q4 2024 | 218 | 96.85M | $1.33B | +1.1% |
表内 8 个季度中,机构持股合计减少 47%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+14.4%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 15.92M | $68.63M | 0.00% | 增持 | |
| 4.80M | $20.68M | 0.00% | 增持 | |
| 4.00M | $17.26M | 0.00% | 减持 | |
| 2.84M | $12.23M | 0.00% | 减持 | |
| 2.50M | $10.77M | 0.01% | 增持 | |
| 2.07M | $8.93M | 0.01% | 增持 | |
| 1.90M | $8.19M | 0.00% | 减持 | |
| 1.72M | $7.42M | 0.00% | 减持 | |
| 1.71M | $7.36M | 0.01% | 增持 | |
| 1.50M | $6.46M | 0.00% | 减持 | |
| 1.09M | $4.70M | 0.01% | 减持 | |
| 958.50K | $4.13M | 0.00% | 增持 | |
| 938.18K | $4.04M | 0.01% | 减持 | |
| 784.45K | $3.38M | 0.00% | 减持 | |
| 708.88K | $3.06M | 0.03% | 增持 | |
| 708.05K | $3.05M | 0.01% | 增持 | |
| 632.89K | $2.73M | 0.00% | 增持 | |
| 450.49K | $1.94M | 0.00% | 新进 | |
| 420.81K | $1.81M | 0.00% | 增持 | |
| 372.85K | $1.61M | 0.01% | 减持 | |
| 362.61K | $1.56M | 0.01% | 增持 | |
| 323.97K | $1.40M | 0.00% | 减持 | |
| 277.49K | $1.20M | 0.00% | 减持 | |
| 270.39K | $1.17M | 0.00% | 增持 | |
| 243.65K | $1.05M | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.42M 股 · $13.80M
- Sixth Street Partners Management Company, L.P. 1.74M 股 · $9.94M
- MACKENZIE FINANCIAL CORP 1.54M 股 · $8.77M
- Militia Capital Management LLC 301.40K 股 · $1.72M
- ExodusPoint Capital Management, LP 212.18K 股 · $1.21M
- PANAGORA ASSET MANAGEMENT INC 204.85K 股 · $1.17M
- Jump Financial, LLC 181.01K 股 · $1.03M
- Jaffetilchin Investment Partners, LLC 89.81K 股 · $512.80K
- ZACKS INVESTMENT MANAGEMENT 81.39K 股 · $464.75K
- UMB Bank, n.a. 57.00K 股 · $325.47K
- NewEdge Advisors, LLC 52.38K 股 · $299.12K
- EntryPoint Capital, LLC 39.84K 股 · $227.47K
完全清仓(较上季)
- ORBIMED ADVISORS LLC 卖出 125.00M 股 · $122.88M
- GLENVIEW CAPITAL MANAGEMENT, LLC 卖出 5.41M 股 · $24.35M
- STATE STREET CORP 卖出 4.42M 股 · $19.91M
- JANE STREET GROUP, LLC 卖出 1.20M 股 · $5.41M
- Fisher Asset Management, LLC 卖出 1.19M 股 · $5.36M
- Y-Intercept (Hong Kong) Ltd 卖出 654.22K 股 · $2.94M
- Renaissance Technologies 卖出 454.37K 股 · $2.04M
- Trexquant Investment LP 卖出 406.10K 股 · $1.83M
- Susquehanna Portfolio Strategies, LLC 卖出 364.15K 股 · $1.64M
- ALGERT GLOBAL LLC 卖出 363.82K 股 · $1.64M
- GSA CAPITAL PARTNERS LLP 卖出 339.90K 股 · $1.53M
- NORDEA INVESTMENT MANAGEMENT AB 卖出 341.48K 股 · $1.49M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 15.92M | 10.89M | 8.89M | 15.30M | 14.88M | 15.07M | 15.46M | 15.91M | 15.44M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 4.80M | — | 4.42M | 5.97M | 4.98M | 4.81M | 5.27M | 5.53M | 4.70M | 4.34M | 5.40M | 4.70M | 4.68M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.00M | 4.08M | 3.92M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.84M | 3.08M | 2.58M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MACKENZIE FINANCIAL CORP | 2.50M | 1.54M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 2.07M | 1.22M | 1.10M | 22.30K | 47.70K | 68.03K | — | — | 114.31K | — | 33.56K | — | — | — | — | 147.00K | — | — | 91.03K | — |
| Morgan Stanley | 1.90M | 2.48M | 3.17M | 3.61M | 3.62M | 4.55M | 1.61M | 1.29M | 880.99K | 1.37M | 1.67M | 835.91K | 554.65K | 646.63K | 625.40K | 896.88K | 684.65K | 717.91K | 577.85K | 457.24K |
| Geode Capital Management | 1.72M | 2.42M | 2.32M | 2.23M | 2.23M | 2.22M | 2.23M | 2.14M | 2.15M | 2.13M | 2.02M | 1.87M | 1.73M | 1.66M | 1.60M | 1.53M | 1.47M | 1.45M | 1.45M | 1.43M |
| Connor, Clark & Lunn Investment Management Ltd. | 1.71M | 1.41M | 1.32M | 1.16M | 1.28M | 1.39M | 921.91K | 549.46K | 115.04K | 21.86K | — | 61.36K | 136.27K | — | — | — | — | — | — | — |
| Nuveen, LLC | 1.50M | 1.55M | 918.96K | 1.19M | 724.90K | 739.03K | 1.18M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 1.09M | 1.67M | 1.69M | 873.13K | 1.19M | 2.05M | 1.42M | 1.00M | 508.62K | 70.78K | — | 19.07K | 131.55K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 958.50K | 772.22K | 585.28K | 490.94K | 398.23K | 348.71K | 172.65K | 104.89K | 69.82K | 56.50K | 15.80K | 15.24K | 15.43K | 15.37K | 15.69K | 6.44K | 16.91K | 16.64K | 16.77K | 522 |
| Assenagon Asset Management S.A. | 938.18K | 1.03M | 1.45M | 1.17M | 1.30M | 325.03K | 84.39K | 164.47K | 167.23K | 250.52K | 197.71K | 132.68K | 276.22K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 784.45K | 1.05M | 739.05K | 1.29M | 1.70M | 2.07M | 2.21M | 2.27M | 2.42M | 2.78M | 2.70M | 2.68M | 2.59M | — | — | — | — | — | — | — |
| Jump Financial, LLC | 708.88K | 181.01K | — | 168.60K | 161.61K | 10.59K | 134.34K | — | 32.86K | — | — | 19.05K | 84.92K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 708.05K | 449.74K | 362.69K | 304.97K | 384.69K | 259.01K | 118.31K | 69.18K | 45.77K | 49.93K | 100 | 90.01K | 41.73K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 632.89K | 622.62K | 615.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 450.49K | — | 1.20M | 54.42K | 224.03K | — | 213.83K | 18.17K | 121.18K | 101.50K | 34.79K | 10.20K | 20.70K | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 420.81K | 85.87K | 85.61K | 77.47K | 55.78K | 10.27K | — | 12.56K | 14.81K | 50.80K | 46.94K | 47.04K | 42.77K | — | — | — | — | — | — | — |
| OP Asset Management Ltd | 372.85K | 449.62K | 148.93K | — | 10.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold MYGN?
As of 2026-Q2, 205 institutional funds reported holding MYGN (MYRIAD GENETICS INC) in SEC 13F filings, with a combined reported value of $564.27M.
How many shares of MYGN do institutions own?
13F filers reported 98.95M shares of MYGN, worth $564.27M in aggregate at the end of 2026-Q2.
Is institutional ownership of MYGN rising or falling?
Share counts moved +9.1% versus the prior quarter — accumulation.
Who are the top institutional holders of MYGN?
The largest 13F holders are ORBIMED ADVISORS LLC, BlackRock Inc, LOOMIS SAYLES & CO L P, Vanguard Group, WELLINGTON MANAGEMENT GROUP LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of MYRIAD GENETICS INC?
The major shareholders of MYRIAD GENETICS INC (MYGN) by reported 13F value are ORBIMED ADVISORS LLC, BlackRock Inc, LOOMIS SAYLES & CO L P, Vanguard Group, WELLINGTON MANAGEMENT GROUP LLP, among 458 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.